Exubera, the new inhaled insulin

July 2006

Patients will soon be trying Exubera, the new inhaled insulin.

Exubera is an alternative to short-acting or regular insulin... for patients with either type 1 or type 2 diabetes.

It has a fast onset...for use up to 10 minutes before meals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote